Snyder P J, Utiger R D
J Clin Invest. 1973 Sep;52(9):2305-12. doi: 10.1172/JCI107419.
Repetitive administration of thyrotropin-releasing hormone (TRH) to human subjects was used to produce small elevations of endogenous serum triiodothyronine (T(3)) and thyroxine (T(4)) levels and thereby to determine the effect of these small elevations on the serum thyrotropin (TSH) response to subsequent doses of TRH. Each subject received 13 consecutive doses of 25 mug TRH at 4-h intervals. Serum T(3), T(4), and TSH levels were measured before the 1st, 7th, and 13th doses ("basal levels") and for the 4 h after each of these doses. In 10 normal subjects, the mean TSH response fell from 14.6 muU/ml after the 1st TRH dose to 6.9 and 3.0 muU/ml after the 7th, and 13th doses. These falls in TSH response were accompanied by rises in the mean basal serum T(3) levels from 81 to 115 to 114 ng/100 ml (normal range, 70-150 ng/100 ml) and rises in the mean basal serum T(4) from 6.7 to 8.6 to 9.5 mug/100 ml (normal range, 5-11 mug/100 ml). These data suggest that TRH-induced TSH release is extremely sensitive to inhibition by small elevations, not above the normal ranges, of serum T(3) and T(4) of endogenous origin. In four patients with primary hypothyroidism, the mean TSH responses were 92, 137, and 92 muU/ml after the 1st, 7th, and 13th TRH doses. The corresponding mean basal serum T(3) and T(4) levels at the times of these doses were 34, 30, and 32 ng/100 ml and 1.9, 1.9, and 1.7 mug/100 ml. These data show that repetitive administration of TRH does not result in progressively lower TSH responses in the absence of corresponding increases in serum T(3) and T(4) level. The progressive fall in TSH response observed in the normal subjects, therefore, was apparently due to the corresponding small increases in serum T(3) and T(4) levels and not to progressive depletion of pituitary TSH. In two patients with presumed TRH deficiency, the TSH responses were blunted by repetitive TRH doses but only when the serum T(3) and T(4) levels increased to within the normal ranges. TRH deficiency was thus confirmed for the first time by producing euthyroidism by replacement of TRH.
对人体受试者重复给予促甲状腺激素释放激素(TRH),以小幅提高内源性血清三碘甲状腺原氨酸(T₃)和甲状腺素(T₄)水平,从而确定这些小幅升高对血清促甲状腺激素(TSH)对后续剂量TRH反应的影响。每位受试者每隔4小时连续接受13剂25μg的TRH。在第1、7和13剂之前(“基础水平”)以及每剂之后的4小时测量血清T₃、T₄和TSH水平。在10名正常受试者中,TSH的平均反应从第1剂TRH后的14.6μU/ml降至第7剂和第13剂后的6.9和3.0μU/ml。TSH反应的这些下降伴随着基础血清T₃平均水平从81 ng/100 ml升至115 ng/100 ml再升至114 ng/100 ml(正常范围70 - 150 ng/100 ml),以及基础血清T₄平均水平从6.7μg/100 ml升至8.6μg/100 ml再升至9.5μg/100 ml(正常范围5 - 11μg/100 ml)。这些数据表明,TRH诱导的TSH释放对内源性血清T₃和T₄小幅升高(未超出正常范围)的抑制极为敏感。在4名原发性甲状腺功能减退患者中,第1、7和13剂TRH后的TSH平均反应分别为92、137和92μU/ml。这些剂量时相应的基础血清T₃和T₄平均水平分别为34、30和32 ng/100 ml以及1.9、1.9和1.7μg/100 ml。这些数据表明,在血清T₃和T₄水平没有相应升高的情况下,重复给予TRH不会导致TSH反应逐渐降低。因此,在正常受试者中观察到的TSH反应逐渐下降显然是由于血清T₃和T₄水平相应的小幅升高,而不是由于垂体TSH的逐渐耗竭。在2名推测存在TRH缺乏的患者中,重复给予TRH剂量会使TSH反应减弱,但仅当血清T₃和T₄水平升高至正常范围内时才会如此。因此,通过补充TRH使甲状腺功能正常,首次证实了TRH缺乏。